The Immunoendocrine Network in Breast Cancer

被引:3
作者
Nava-Castro, Karen E. [1 ]
Palacios-Arreola, Margarita I. [2 ]
Ostoa-Saloma, Pedro [2 ]
Muniz-Hernandez, Sae [3 ]
Cerbon, Marco A. [4 ]
Gomez-Icazbalceta, Guillermo [4 ]
Munoz-Cruz, Samira [5 ]
Aguilar-Diaz, Hugo [4 ]
Pavon, Lenin [6 ]
Ivone Castro-Romero, Julieta [1 ]
Morales-Montor, Jorge [2 ]
机构
[1] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico
[2] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, AP 70 228, Mexico City 04510, DF, Mexico
[3] Secretaria Salud SSA, Inst Nacl Cancerol, Subdirecc Invest Basica, Mexico City, DF, Mexico
[4] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Mexico City, DF, Mexico
[5] Inst Mexicano Seguro Social, Unidad Invest Med Enfermedades Infecciosas & Para, Mexico City, DF, Mexico
[6] Inst Nacl Psiquiatria Ramon de la Fuente, Direcc Invest Neurociencias, Lab Psicoinmunol, Mexico City, DF, Mexico
关键词
Breast cancer; sex steroids; immune response; immunoendocrine network;
D O I
10.3233/NIB-140097
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Breast cancer is a disease in which abnormal cell proliferation leads to uncontrolled growth of breast tissue. Breast cancer can start in various areas of the breast, such as the ducts, lobes, and, in some cases, the intervening tissue. For many years, inflammatory infiltrates in tumors have been suggested to reflect the origin of cancer; however, little is known about the function of chronic inflammation in malignant transformation. Sex hormones are associated with many types of cancer, such as colon, cervical, and especially breast. Estrogen-dependent breast cancer (EDBC) constitutes approximately 50% to 80% of all cases of breast cancer. Furthermore, estrogen-dependency is linked to the initiation of malignancy by promoting the growth and proliferation of mammary cells and it is related to prognosis and treatment. The correlation between sex hormones and breast cancer has been recognized for decades, but the mechanisms of this association remain unknown. In recent years, a more enriched landscape of this relationship has emerged. Intervention by the immune system in cancer begins with the detection of transformed cells and their proliferation-not with the defense and effort to restrain an established tumoral mass. In the late 1950s, Burnet introduced the immunosurveillance theory, which proposes that immune system cells detect and attack transformed cells, eliciting an adaptive response that succeeds and eliminates them or fails, leading to the formation of a tumoral mass and cancer onset. Conversely, sex hormones are important modulators of the immune system. Growing evidence demonstrates a reciprocal relationship between sex steroids and the immune system. Because the innate immune response determines the type of adaptive immunity that develops, hormonal effects on the former can affect adaptive responses. The sex steroids estrogens, progesterone, and testosterone regulate the growth, differentiation, survival, and function of many cell types that mediate homeostasis, immunity, and breast cancer. The presence of sex steroid receptors on immune cells indicates that sex steroids exert their effects by binding to them. Sex steroids and immunity are inextricably linked, and their mutual regulation influences the maintenance of the immune balance. Understanding the mechanisms of action of sex steroids on immune cells is paramount to developing novel therapies for chronic diseases that are associated to immune dysregulation, such as breast cancer. This chapter describes the risk factors in breast cancer, the hormonal factors that are involved, the immunological response toward cancer, and the effects of sex steroids on immune system cells and their implications for the incidence of breast cancer.
引用
收藏
页码:109 / 131
页数:23
相关论文
共 134 条
[1]  
AALTOMAA S, 1993, ANTICANCER RES, V13, P785
[2]   Estrogen and colon cancer: current issues [J].
Al-Azzawi, F ;
Wahab, M .
CLIMACTERIC, 2002, 5 (01) :3-14
[3]   Mast cells and eosinophils in invasive breast carcinoma [J].
Amini, Rose-Marie ;
Aaltonen, Kirsimari ;
Nevanlinna, Heli ;
Carvalho, Ricardo ;
Salonen, Laura ;
Heikkila, Paivi ;
Blomqvist, Carl .
BMC CANCER, 2007, 7 (1)
[4]  
Armstrong MD, 2001, ARCH IMMUNOL THER EX, V49, P231
[5]  
Arteaga M, 2002, REV INVEST CLIN, V54, P542
[6]   Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients [J].
Azab, Basem ;
Bhatt, Vijaya R. ;
Phookan, Jaya ;
Murukutla, Srujitha ;
Kohn, Nina ;
Terjanian, Terenig ;
Widmann, Warren D. .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (01) :217-224
[7]   Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists [J].
Badve, Sunil ;
Dabbs, David J. ;
Schnitt, Stuart J. ;
Baehner, Frederick L. ;
Decker, Thomas ;
Eusebi, Vincenzo ;
Fox, Stephen B. ;
Ichihara, Shu ;
Jacquemier, Jocelyne ;
Lakhani, Sunil R. ;
Palacios, Jose ;
Rakha, Emad A. ;
Richardson, Andrea L. ;
Schmitt, Fernando C. ;
Tan, Puay-Hoon ;
Tse, Gary M. ;
Weigelt, Britta ;
Ellis, Ian O. ;
Reis-Filho, Jorge S. .
MODERN PATHOLOGY, 2011, 24 (02) :157-167
[8]   Circulating Steroid Hormone Levels and Risk of Breast Cancer for Postmenopausal Women [J].
Baglietto, Laura ;
Severi, Gianluca ;
English, Dallas R. ;
Krishnan, Kavitha ;
Hopper, John L. ;
McLean, Catriona ;
Morris, Howard A. ;
Tilley, Wayne D. ;
Giles, Graham G. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (02) :492-502
[9]   Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases [J].
Bardou, VJ ;
Arpino, G ;
Elledge, RM ;
Osborne, CK ;
Clark, GM .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) :1973-1979
[10]   Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains [J].
Bebo, BF ;
Fyfe-Johnson, A ;
Adlard, K ;
Beam, AG ;
Vandenbark, AA ;
Offner, H .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :2080-2089